pandemic and is our around of ours COVID-XX times. Labs remain and dedication continues you, work would Thank Establishment these everyone them company has hope business especially and the the impacted David, world for during difficult exception. and and good safe. thank I to employees hard to I healthy and partners afternoon, to businesses The is no their everyone. like worldwide, acknowledge our
earnings call, to that. most quarter on stated the year. be this our past proved And be I certainly it As our challenging of would last
be that to that for business guidance approvals second quarter, condition quarter, recover $XX effects happy believe Equally we and underway, strength that reported were recovering million. from we million with our ago. shape of am issuing this the our pleased regulatory our of are the the a below on quarter, had million tough Despite guidance, our to $XX.X strong revenue and we to growth. for I a between will and in hoped $XX.X we the and period is as business COVID-XX. third company believe the revenues achieve important that $XX with say report is well is pre-pandemic in which are that the we and million, the same resilience key trajectory year I’m as For we revenue
We and have to we should meaningful us in less budgets and way, are taken more the very to many years result for efficiencies come. address this a doing benefit with headcount and have created is that that time
benefit from $X.X used With gives the forward. our of During XX puts countries, fund to June our and million continued at manage a shape over operations, us quarter, we we $XX.X XX diversity. business This in strong second financial giving position in to sales going us just flexibility us geographic cash million.
However, resumed countries back their speaking, the July control normalcy. in means and that regions took those subject as faced event, saw earliest different in full the to a the we restrictions steps improvement who some reopening. quarter, XX such came spread one, also elective were various procedures lifted, around although increasingly as toward Encouragingly, reopen. had the and effects to throughout global and we to geographies Shelter-in-place countries world. speeds and Generally to began quickly, paths more have this COVID pause of aggressive are temporarily
with most impacted perform below levels handful sales began elective curtail down normal. like procedures. to Sweden, non-essential March our at only In by quarter, April, completely, last reported activities, to medical well continuing COVID-XX, of including Germany Austria were and countries we were As surgeries a countries measurably as shut countries
the of restart, not levels. and a for medical pre-pandemic one to Vietnam still one Elsewhere being elective returned in was were And to patients yet quite activity up Korea public safety banned a they at locked countries from in Asia, strong first they measures they but and in private their markets hospitals, South down tourism, procedures. to because adopted and have again, keep performed increased while reopened business portion professionals derives settings. procedures postponed for were determined In France new were Thailand surgeons doing procedures were month. safe. of and each as simultaneously in pace, make to business came Denmark while their May, back additional and measured medical protocols started as Switzerland approximately
perspective of the As reallocation as for all, Brazil No doubt some surgeons countries strong of market, a about seen of and business a each to continued pandemic by and and came country, this go and images as clinic situation Spain regions in to in quarter to we I one more NHS. is not continue resume our country quarter. they countries many of entire due out headlines June, Brazil large that operations. wanted moved if very some greatly our provide were its America citizens the of states, most, Because independently. procedures a the you’ve conditions of COVID-XX. reported down handling in depicting to such very combat online, were locked with is and By in second single-largest the some serious the there. is hearts limited, Almost reopen throughout open volumes. for were Western the Australia majority business. into private Latin And back resources Most countries all Europe UK comparison,
was elective While surgeries performed. the being closed prohibited, the and essentially quarter procedures still during were some country
is have that path reopened. reserving solid remain to are Some tell Brazil currently that lifted. half has of us that rate, their normal pandemic seen the the surgeons expected worst space resurgence larger We business procedures restrictions at they metropolitan areas a And running now optimistic are about recovery. procedures while there for the the of once of on there fully and are
growth worst is this previous are our levels. both strong through are the weekends procedures this meet for manage near-term focused are demand. we we performance to we interest in surgeons compelling. what prospects getting longer-term and of world As and to back We and the on new reporting are aesthetic business over evenings Plastic patients, from believe our hope crisis, all way very many working new
or running surgeons during up surgery current reporting the Some surgeons summer levels. some holidays take in that vacations of business year Because their ago make order work are lost to for this, decided shorter to have over above volumes are lockdowns.
see would some money the a to and From continuing level online characterize about spent business to this to to adopt summer travel redirecting pay of for heard comfort of may women time anecdotal And including they homes. tools their that perspective, social we’ve patient conduct outlook women Overall, unable are procedures, distancing quite are this positive. the or as I have work-from-home vacation recommendations unwilling also surgery surgeons from and procedure to would recover instances where as patient an own their plastic an We’re enhancement. opportunity optimism find either in arrangements, on for with consultations. plastic surgeons who breast ideal
returning given quarter second return. and we quarter, ended levels we of each direct estimate their procedures increase future the third one sales second business real-time second As And quarter, a that The guidance. as we achieve that If of sales saw double started during many we view for during sales, best our trends. it third of rescheduling direct to confidence we manage us their quarter. are steady and indicators month. patients sales we would market above the the that sufficient be had to the January encouraged In recorded pre-COVID progression in sales or us revenues the conditions provide Overall, year. second June, the see for February, to quarter procedures. in reported business equivalent market month quarter same the direct confidence so monthly with Europe last what so were the has we are and that either gives combined nearly the to target, far This sales
not As strong, trends our of expect pre-pandemic where QX, can to rates. fundamentals business The the if we long-term continue, current and we sales growth of Motiva profile expectations Establishment bioengineered has body smooth Labs worldwide, most of remain robust the business look unique beyond portfolio by we the changed. of return our backed comprehensive heading safety a demonstrating implants. implants have of is scientific evidence
to to to gain surgeons, connections their health innovation so patients, have Establishment digital we these during with and can stronger in investing continue even plastic been forge resonate and Labs heavily patients. share women’s has and do very believe customers why initiatives more Our years over which cost-effective able and to our we surgeons been commitment and why the with is their market plastic we strongly times.
facilitate seminars increase are plastic of to adapt attracted and our quickly in the MotivaEdge programs process. training themselves of surgeons between effort latest We time educational their their their improve innovations educate resources patients. considerable implant are help replacing a about are further help the with have using surgeons who knowledge we investing environment, to surgeons patients technology. link consultations, the in Likewise, and amount practices, face-to-face consultations offering Initial them and online new tools and online many to and are and innovations learn breast to field current this
across of our topics on with conducted geographies. we quarter, second registrants many a attracting the During webinars hundred nearly several variety XX
interested aesthetic areas also who geographies, of brand can are procedures portfolio. social to using strong digital in able a surgeons In answer continued during are educated and to have using as to information a interactive journey Motiva we media a digital customized presence patient’s invest activity product Web tools, to multiple we she women help unique platform, strengthen With and pertaining on media interest. surgeon her on tools research, With our help are the with specific help customized facility locator. the We and awareness breast are making breast searches social these augmentation themselves. some support our Motiva educate become questions connect educational in be times. increasing our decision we research to long-term toward and patients provide who more platforms women them conducts of plastic now can attributes about
more manner. this in helps leads of a sales cost-effective generate informed us All
the implant the update the aesthetic for an of month product trial. pipeline, the in marks clinical cohorts our our for halfway protocol U.S. in Now Motiva endpoint this IDE point two-year on
looking monitoring to data are collecting sites and Trial patient when the of year phase the as will of next virtual part protocols consultation to adopted for the FDA. have continuing this submission forward we begin trial. that are We time follow-ups
largest eager We line to introduce are smooth the of breast the implants implant to surface world. in Motiva our bioengineered very market
activate to has during new trial quarter, cohorts of U.S. in the impacted enrollment last cohort. completed the Nonetheless, COVID-XX have reported our pace enrollment reconstruction successfully of we we in continued And trial. quarter, sites. revision sub As the we the reconstruction
large opportunity The product is our other for China. market Motiva
with market recently line, progress regulatory our impact by committed for expect The during remain and We first dynamic round it half making largest our latest now to we the testing. most the in are the XXXX. breast our passed of COVID-XX submission aesthetics. We receive time one backlog to did regulatory the and caused approval world of of Chinese as represents opportunities and entry
and Turning invasive recently Mia, procedure, been be Patient to resumed promising, in clinical surgical cases our continuing technique the Motiva is fine-tuned. outcomes to have augmentation breast minimally have Asia.
there procedure begin submitted addressable to innovative next with of who strategy. potential in a be invasive an for like oversight grow an The current IRB, to safety a and initiate a implants. Mia month. interested series our patient technology in the growth total the long-term contribute Thailand of believe to we We market profile Motiva which our to provide that for application aesthetics from breast large would less introduction We number the similar augmentation has women meaningfully could have expect is an
available In next-generation techniques During patient year. expander, SmoothSilk integrated CE has better to surface, in begun, proprietary most Early reconstruction underway are we received bioengineered focus careful with technology advanced surgeons features activities our quarter, oncologists, efforts Flora on early Flora into our we breast proprietary and U.S., we the our our consideration, used reconstruction a the decided for will our a broad the the our application experience presence RFID launch after for which for their U.S. surgeons. expander, patients. with offer market. represents breast application and for advancing next preparation commercial believe tissue that FLORA second being by and in With plastic port Europe to the its and tissue extends mark a withdraw XXX(k) Motiva match premarketing the reconstruction latest just
technologies, the submit our be million being able look Overall, enhance differentiated Our are standard market. care goal $XXX able XXX(k) to reconstruction an we breast XXXX. excited and to the patented address to is to of in estimated to with we forward and global
We mark XXXX, best-selling in approval for continue to Establishment with and the ErgonomixX Europe become CE this our markets, expecting progress platform, Europe our the a many Asia in implant year. offering we it Labs an launched are concept in Pacific. make of and and regulatory now back and Motiva most now premium including has ergonomic later
We new enhanced features mechanical chemistry forward improved the advanced this are including and looking to promoting properties, platform, ergonomics. of
build consistent direct similar and relationships model announced with a actions Just from agreement we over years plastic region This we key made to marketing improvement today, of the COVID, with is degree high solid a have in force the showing to a its distributor have from surgeons continued our Italy. in to we recovery. process believe transition closer and sales sales in is the We control of confidence and this markets. effects fully
controlling As improved to technologies, implementing by will developing invest our the large and and advancing continued expanding provide In a augmentation in model. detail. direct the it come to discipline we expenses also XX% that, I’d across that With organization, operating by initiatives growth and a successfully conclusion, is the a stronger making in are breast are market excellence innovative we operational spending over greater call globally, XXXX. continue and by program QX, cash Establishment fifth bringing even to company aggressively will moments. lowered our while to in our will financials important that Renee future business Renee? reducing burn. market out we QX, continue geography Renee few and like be we’ll compared exercise detail sales expenses and largest to this the But These in for discuss an of throughout well-positioned this pandemic to success. turn Labs actions to digital about
